Rigel Pharmaceuticals | RIGL - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Agenus USD 82.99M 2.3M 2025-12
Amgen USD 19.52B 1.37B 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Celldex Therapeutics USD 1.18M 3.09M 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Pfizer USD 4.51B 734M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Ultragenyx Pharmaceutical USD 31M 9.57M 2025-12
Veracyte USD 4.59M 916K 2025-12